Hemodialysis And Peritoneal Dialysis Market Growth Amid Rising Kidney Disorders

The global hemodialysis and peritoneal dialysis market was valued at USD 119.49 billion in 2025 and is expected to reach USD 250.38 billion by 2033, expanding at a CAGR of 9.84% from 2026 to 2033. Market growth is primarily driven by the increasing incidence of acute kidney injury (AKI), a growing shortage of organ donors, risks associated with kidney transplantation, continuous technological advancements, and strategic initiatives by leading companies to introduce innovative dialysis products and services.

Key Market Trends & Insights

• North America held the largest share of the global hemodialysis and peritoneal dialysis market in 2025.
• The U.S. represented the highest revenue contributor within the North American market.
• By type, hemodialysis accounted for the largest market share in 2025.
• By product type, the services segment generated the highest revenue share.
• By end use, the hospital-based segment dominated the market in 2025.
• Growing adoption of home-based dialysis solutions is improving patient convenience and treatment accessibility.
• Technological innovations in dialysis equipment and monitoring systems are enhancing treatment outcomes and operational efficiency.
• Increasing awareness and early screening programs for chronic kidney disease (CKD) are contributing to a larger diagnosed patient population requiring renal replacement therapies.

Market Size & Forecast

Metric	Value
Market Size (2025)	USD 119.49 Billion
Projected Market Size (2033)	USD 250.38 Billion
CAGR (2026–2033)	9.84%
Largest Regional Market	North America
Fastest-Growing Region	Asia Pacific

Market Dynamics

The growing prevalence of chronic kidney disease (CKD) remains one of the most significant factors driving demand for hemodialysis and peritoneal dialysis therapies worldwide. Any condition that impairs kidney function can eventually lead to CKD, which may progress to End-Stage Renal Disease (ESRD) if left untreated. Patients diagnosed with ESRD require long-term renal replacement therapies, including dialysis, to sustain life.

Download a free sample copy of the Hemodialysis And Peritoneal Dialysis Market report to understand detailed coverage and inclusions in the final report

The global burden of CKD has increased substantially due to the rising prevalence of lifestyle-related disorders such as diabetes, hypertension, and obesity. These conditions are among the leading causes of kidney damage and have contributed to a growing patient population requiring dialysis treatment. Additionally, CKD often develops gradually and presents minimal symptoms during its early stages, resulting in delayed diagnosis and a greater likelihood of progression to ESRD.

Improved healthcare awareness, expanded screening initiatives, and better diagnostic capabilities have enabled earlier identification of kidney diseases. As a result, more patients are being diagnosed and monitored, increasing demand for dialysis services and products. Environmental factors, including exposure to harmful toxins and poor water quality in certain regions, have also been linked to the rising incidence of kidney-related disorders.

The increasing number of CKD and ESRD patients is encouraging healthcare providers and industry participants to invest in dialysis infrastructure, specialized treatment centers, and home-based dialysis solutions. Furthermore, technological advancements in dialysis systems are helping improve patient outcomes, treatment efficiency, and overall quality of care, supporting long-term market expansion.

Looking for more specific insights? Customize this report to suite your business needs

Competitive Landscape and Company Insights

Leading companies operating in the hemodialysis and peritoneal dialysis market are actively pursuing growth through product innovation, regulatory approvals, strategic partnerships, acquisitions, collaborations, and geographic expansion. Significant investments in research and development are also being made to improve dialysis technologies and expand treatment accessibility.

For example, in April 2023, Outset Medical, Inc. continued its efforts to simplify and reduce the cost of dialysis through its Tablo Hemodialysis System. During the National Kidney Foundation Spring Clinical Meetings, the company presented five new research abstracts highlighting the clinical and economic benefits of home hemodialysis (HHD), gender-related disparities affecting female nephrologists, and other important kidney disease topics. Such initiatives reflect the industry’s growing focus on patient-centered care, home treatment solutions, and improved healthcare efficiency.

The market is also witnessing increased emphasis on digital monitoring technologies, remote patient management, and portable dialysis systems. These innovations are expected to support broader adoption of home dialysis therapies while reducing the burden on hospital-based facilities.

Explore Grand View Horizon to see global and regional level statistics related to the Hemodialysis And Peritoneal Dialysis Market

Key Companies in the Hemodialysis and Peritoneal Dialysis Market

Major participants operating in the global market include:

• Baxter
• B. Braun SE
• Fresenius Medical Care AG
• Medtronic
• Asahi Kasei Medical Co., Ltd.
• Nipro Corp.
• DaVita (Optum)
• BD
• Nikkiso Co., Ltd.
• Cantel Medical (STERIS plc)
• Diaverum (M42)
• vivISOL

These organizations continue to strengthen their market presence through innovation, service expansion, strategic collaborations, and investments in advanced renal care solutions.

Conclusion

The global hemodialysis and peritoneal dialysis market is poised for substantial growth through 2033, supported by the increasing prevalence of chronic kidney disease and end-stage renal disease worldwide. Rising rates of diabetes, hypertension, and obesity, combined with improved disease detection and growing awareness, are expanding the patient population requiring dialysis treatment. Continuous advancements in dialysis technologies, increasing adoption of home-based therapies, and ongoing investments by leading market players are further accelerating industry development. With North America maintaining its leadership position and Asia Pacific emerging as the fastest-growing region, the market is expected to witness sustained expansion as healthcare systems focus on improving renal care accessibility, treatment outcomes, and patient quality of life.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare